FDA approves Alzheimer's drug for mild, early-stage diseaseFDA approves Alzheimer's drug for mild, early-stage diseaseFDA approves Alzheimer's drug for mild, early-stage disease

FDA approves Alzheimer's drug for mild, early-stage disease

The drug is the first that’s been convincingly shown to slow the decline in memory and thinking by targeting the disease's underlying biology.

from Section Page News - Modern Healthcare https://ift.tt/F8o5IHl